Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edelgard Lindhoff-Last

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 19, 2024
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTHJerrold H Levy, Joseph R Shaw, Lana A Castellucci, et al.
Thrombosis and Haemostasis|January 26, 2011
Molecular basis of antithrombin deficiencyBeate Luxembourg, Daniel Delev, Christof Geisen, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients-Results of the Prospective RADOA RegistryJana Last, Ingvild Birschmann, Simone Lindau, et al.
Neurological Research and Practice|May 1, 2022
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registryWaltraud Pfeilschifter, Edelgard Lindhoff-Last, Ali Alhashim, et al.
Journal of Clinical Medicine|January 11, 2024
Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists-Results of the German Prospective RADOA-RegistryJana Last, Eva Herrmann, Ingvild Birschmann, et al.
Journal of the American College of Cardiology|November 25, 2017
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced ThrombocytopeniaMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
Thrombosis Research|April 8, 2014
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry studyMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
Deutsches Arzteblatt International|July 2, 2020
Severe Hemorrhage Associated With Oral AnticoagulantsEdelgard Lindhoff-Last, Eva Herrmann, Simone Lindau, et al.
Thrombosis and Haemostasis|July 13, 2021
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-RegistryEdelgard Lindhoff-Last, Ingvild Birschmann, Joachim Kuhn, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Pharmacokinetics of Phenprocoumon in Emergency Situations-Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)Edelgard Lindhoff-Last, Ingvild Birschmann, Antonia J Bidenharn, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Thrombosis and Haemostasis : JTH|July 19, 2024
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTHJerrold H Levy, Joseph R Shaw, Lana A Castellucci, et al.
Thrombosis and Haemostasis|January 26, 2011
Molecular basis of antithrombin deficiencyBeate Luxembourg, Daniel Delev, Christof Geisen, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients-Results of the Prospective RADOA RegistryJana Last, Ingvild Birschmann, Simone Lindau, et al.
Neurological Research and Practice|May 1, 2022
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registryWaltraud Pfeilschifter, Edelgard Lindhoff-Last, Ali Alhashim, et al.
Journal of Clinical Medicine|January 11, 2024
Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists-Results of the German Prospective RADOA-RegistryJana Last, Eva Herrmann, Ingvild Birschmann, et al.
Journal of the American College of Cardiology|November 25, 2017
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced ThrombocytopeniaMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
Thrombosis Research|April 8, 2014
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry studyMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
Deutsches Arzteblatt International|July 2, 2020
Severe Hemorrhage Associated With Oral AnticoagulantsEdelgard Lindhoff-Last, Eva Herrmann, Simone Lindau, et al.
Thrombosis and Haemostasis|July 13, 2021
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-RegistryEdelgard Lindhoff-Last, Ingvild Birschmann, Joachim Kuhn, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Pharmacokinetics of Phenprocoumon in Emergency Situations-Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)Edelgard Lindhoff-Last, Ingvild Birschmann, Antonia J Bidenharn, et al.
Pageof 12